PM To Visit 3 Top Coronavirus Vaccine Maker Company Today, Hyderabad Is Second Stop After Gujarat

PM To Visit 3 Top Coronavirus Vaccine Maker Company Today, Hyderabad Is Second Stop After Gujarat 

New Delhi: PM Modi is visiting India's top vaccine hubs today to personally review the development of the coronavirus vaccine and the manufacturing process.

PM Modi's office said the visit was meant to help him get a "first-hand perspective of the preparations, challenges, and roadmap in India's endeavor to vaccinate its citizens".

PM Modi began his three-city vaccine tour with a visit to the pharma major Zydus Cadila's plant in Gujarat.PM Modi wearing a PPE Kit, reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area, over 20 km from Ahmedabad.

#WATCH Prime Minister Narendra Modi visits Zydus Biotech Park in Ahmedabad, reviews the development of #COVID19 vaccine candidate ZyCOV-D pic.twitter.com/vEhtNMf1YE

— ANI (@ANI) November 28, 2020

Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA-based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey," PM Modi tweeted.

The plant is located in the Changodar industrial area, over 20km from Ahmedabad.

As India enters a decisive phase of the fight against Covid-19, PM @narendramodis's visit to these facilities & discussions with the scientists will help him get a first-hand perspective of the preparations, challenges & roadmap in India’s endeavor to vaccinate its citizens,” tweeted PM's office on Saturday.

As per the reports, the PM will first visit the pharma major Zydus Cadila's plant around 9.30 am. The Zydus Cadila had announced that the phase-1 clinical trial of its vaccine candidate yCoV-D was over and it has commenced phase-II clinical trials from August.

PM Modi from Ahmedabad will fly to Hyderabad to visit the vaccine maker Bharat Biotech's facility where he is expected to spend an hour. Bharat Biotech’s Covaxin is undergoing phase-3 trials.

Also, he will arrive at Pune's Serum Institute of India, his last destination for the day, at around 4.30 pm. Also, he will review the status of the vaccine candidate that is being manufactured by the Jenner Institute of Oxford University in collaboration with British-Swedish pharma company AstraZeneca.

Both University of Oxford and AstraZeneca on Monday said that their vaccine was up to 90% effective in late-stage clinical trials, raising hopes for its arrival in India by the end of the year.

(With agency inputs)

India News With Breaking News And Latest News From India and World follow dailyaddaa, like us on Facebook, Follow us on Twitter and Subscribe us for Latest Videos